Please login to the form below
Kisplyx
This page shows the latest Kisplyx news and features for those working in and with pharma, biotech and healthcare.
NICE gives green light to Ipsen's Cabometyx
Meanwhile, NICE is in the process of assessing Eisai’s Kisplyx (lenvatinib) - approved by European regulators in 2016 as a second-line combination treatment for advanced RCC, guidance from England’s
Latest news
-
Eisai wins EU licence for kidney cancer drug Kisplyx
Eisai wins EU licence for kidney cancer drug Kisplyx. Approved as a second-line combination treatment for advanced RCC. ... The European Commission has approved Kisplyx (lenvatinib) for the treatment of adults with advanced renal cell carcinoma (RCC)
-
HIV prevention pill heads July CHMP recommendations
HIV prevention pill heads July CHMP recommendations. Gilead’ s Truvada given positive opinion alongside Ipsen Pharma’ s Cabometyx and Eisai’ s Kisplyx. ... The panel also recommended approval of two targeted kidney cancer medicines - Ipsen Pharma's
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Featured jobs
- Director, Market Access / HEOR - North-West
-
Negotiable
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Senior Medical Writer
-
Great salary and benefits
-
Associate Medical Director
-
Highly Competitive
- Events Manager – Med Comms – Surrey
-
Salary TBC
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Account Director
-
Excellent benefits
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Senior Account Manager
-
Negotiable
-
Account Director
-
£48, 000 - £60, 000
-
Medical/ Scientific Director
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
Subscribe to our email news alerts
- Key considerations for disease- modifying Parkinson’s disease trials
- Artificial Intelligence In Healthcare Market to Witness Exponential Growth by 2027
- Breathing Exercise Devices Market Intelligence Report Offers Growth Prospects
- Micro-CT Scanners Market 10-Year Market Forecast and Trends Analysis Research Report
- Next Generation Infusion Pump Market Healthy Pace throughout the Forecast during 2017 – 2027
- Wireless Brain Sensors Market Intelligence Report Offers Growth Prospects
PMHub
Real Science Communications
Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
